6-[[(2S)-1-amino-1-oxopropan-2-yl]amino]-2-[1-(2-methylpropyl)indol-5-yl]pyrimidine-4-carboxamide;6-(3-formyl-1H-indol-5-yl)-N-[4-(trifluoromethyl)phenyl]pyridine-2-carboxamide;6-[1-(2-methylpropyl)indol-5-yl]pyridine-2-carbaldehyde;6-[[(3S)-2-oxopyrrolidin-3-yl]amino]-2-[1-[4-(trifluoromethyl)phenyl]benzimidazol-5-yl]pyrimidine-4-carboxamide

C83H74F6N18O7 — CID 158029926

IUPAC6-[[(2S)-1-amino-1-oxopropan-2-yl]amino]-2-[1-(2-methylpropyl)indol-5-yl]pyrimidine-4-carboxamide;6-(3-formyl-1H-indol-5-yl)-N-[4-(trifluoromethyl)phenyl]pyridine-2-carboxamide;6-[1-(2-methylpropyl)indol-5-yl]pyridine-2-carbaldehyde;6-[[(3S)-2-oxopyrrolidin-3-yl]amino]-2-[1-[4-(trifluoromethyl)phenyl]benzimidazol-5-yl]pyrimidine-4-carboxamide
SMILESCC(C)Cn1ccc2cc(-c3cccc(C=O)n3)ccc21.CC(C)Cn1ccc2cc(-c3nc(N[C@@H](C)C(N)=O)cc(C(N)=O)n3)ccc21.NC(=O)c1cc(N[C@H]2CCNC2=O)nc(-c2ccc3c(c2)ncn3-c2ccc(C(F)(F)F)cc2)n1.O=Cc1c[nH]c2ccc(-c3cccc(C(=O)Nc4ccc(C(F)(F)F)cc4)n3)cc12
InChIInChI=1S/C23H18F3N7O2.C22H14F3N3O2.C20H24N6O2.C18H18N2O/c24-23(25,26)13-2-4-14(5-3-13)33-11-29-16-9-12(1-6-18(16)33)21-31-17(20(27)34)10-19(32-21)30-15-7-8-28-22(15)35;23-22(24,25)15-5-7-16(8-6-15)27-21(30)20-3-1-2-18(28-20)13-4-9-19-17(10-13)14(12-29)11-26-19;1-11(2)10-26-7-6-13-8-14(4-5-16(13)26)20-24-15(19(22)28)9-17(25-20)23-12(3)18(21)27;1-13(2)11-20-9-8-15-10-14(6-7-18(15)20)17-5-3-4-16(12-21)19-17/h1-6,9-11,15H,7-8H2,(H2,27,34)(H,28,35)(H,30,31,32);1-12,26H,(H,27,30);4-9,11-12H,10H2,1-3H3,(H2,21,27)(H2,22,28)(H,23,24,25);3-10,12-13H,11H2,1-2H3/t15-;;12-;/m0.0./s1
InChIKeyFHBDDMQCDRMQOW-XVUAEVNCSA-N
MW1549.61 g/mol
LogP14.52
Rot. Bonds20

About 6-[[(2S)-1-amino-1-oxopropan-2-yl]amino]-2-[1-(2-methylpropyl)indol-5-yl]pyrimidine-4-carboxamide;6-(3-formyl-1H-indol-5-yl)-N-[4-(trifluoromethyl)phenyl]pyridine-2-carboxamide;6-[1-(2-methylpropyl)indol-5-yl]pyridine-2-carbaldehyde;6-[[(3S)-2-oxopyrrolidin-3-yl]amino]-2-[1-[4-(trifluoromethyl)phenyl]benzimidazol-5-yl]pyrimidine-4-carboxamide

6-[[(2S)-1-amino-1-oxopropan-2-yl]amino]-2-[1-(2-methylpropyl)indol-5-yl]pyrimidine-4-carboxamide;6-(3-formyl-1H-indol-5-yl)-N-[4-(trifluoromethyl)phenyl]pyridine-2-carboxamide;6-[1-(2-methylpropyl)indol-5-yl]pyridine-2-carbaldehyde;6-[[(3S)-2-oxopyrrolidin-3-yl]amino]-2-[1-[4-(trifluoromethyl)phenyl]benzimidazol-5-yl]pyrimidine-4-carboxamide (PubChem CID 158029926) has the molecular formula C83H74F6N18O7 and a molecular weight of 1549.61 g/mol. Its IUPAC name is 6-[[(2S)-1-amino-1-oxopropan-2-yl]amino]-2-[1-(2-methylpropyl)indol-5-yl]pyrimidine-4-carboxamide;6-(3-formyl-1H-indol-5-yl)-N-[4-(trifluoromethyl)phenyl]pyridine-2-carboxamide;6-[1-(2-methylpropyl)indol-5-yl]pyridine-2-carbaldehyde;6-[[(3S)-2-oxopyrrolidin-3-yl]amino]-2-[1-[4-(trifluoromethyl)phenyl]benzimidazol-5-yl]pyrimidine-4-carboxamide.

Molecular Properties

Compound Name6-[[(2S)-1-amino-1-oxopropan-2-yl]amino]-2-[1-(2-methylpropyl)indol-5-yl]pyrimidine-4-carboxamide;6-(3-formyl-1H-indol-5-yl)-N-[4-(trifluoromethyl)phenyl]pyridine-2-carboxamide;6-[1-(2-methylpropyl)indol-5-yl]pyridine-2-carbaldehyde;6-[[(3S)-2-oxopyrrolidin-3-yl]amino]-2-[1-[4-(trifluoromethyl)phenyl]benzimidazol-5-yl]pyrimidine-4-carboxamide
PubChem CID158029926
Molecular FormulaC83H74F6N18O7
Molecular Weight1549.61 g/mol
Exact Mass1548.59
IUPAC Name6-[[(2S)-1-amino-1-oxopropan-2-yl]amino]-2-[1-(2-methylpropyl)indol-5-yl]pyrimidine-4-carboxamide;6-(3-formyl-1H-indol-5-yl)-N-[4-(trifluoromethyl)phenyl]pyridine-2-carboxamide;6-[1-(2-methylpropyl)indol-5-yl]pyridine-2-carbaldehyde;6-[[(3S)-2-oxopyrrolidin-3-yl]amino]-2-[1-[4-(trifluoromethyl)phenyl]benzimidazol-5-yl]pyrimidine-4-carboxamide
SMILESCC(C)Cn1ccc2cc(-c3cccc(C=O)n3)ccc21.CC(C)Cn1ccc2cc(-c3nc(N[C@@H](C)C(N)=O)cc(C(N)=O)n3)ccc21.NC(=O)c1cc(N[C@H]2CCNC2=O)nc(-c2ccc3c(c2)ncn3-c2ccc(C(F)(F)F)cc2)n1.O=Cc1c[nH]c2ccc(-c3cccc(C(=O)Nc4ccc(C(F)(F)F)cc4)n3)cc12
InChIInChI=1S/C23H18F3N7O2.C22H14F3N3O2.C20H24N6O2.C18H18N2O/c24-23(25,26)13-2-4-14(5-3-13)33-11-29-16-9-12(1-6-18(16)33)21-31-17(20(27)34)10-19(32-21)30-15-7-8-28-22(15)35;23-22(24,25)15-5-7-16(8-6-15)27-21(30)20-3-1-2-18(28-20)13-4-9-19-17(10-13)14(12-29)11-26-19;1-11(2)10-26-7-6-13-8-14(4-5-16(13)26)20-24-15(19(22)28)9-17(25-20)23-12(3)18(21)27;1-13(2)11-20-9-8-15-10-14(6-7-18(15)20)17-5-3-4-16(12-21)19-17/h1-6,9-11,15H,7-8H2,(H2,27,34)(H,28,35)(H,30,31,32);1-12,26H,(H,27,30);4-9,11-12H,10H2,1-3H3,(H2,21,27)(H2,22,28)(H,23,24,25);3-10,12-13H,11H2,1-2H3/t15-;;12-;/m0.0./s1
InChIKeyFHBDDMQCDRMQOW-XVUAEVNCSA-N
XLogP14.52
TPSA366.48 Ų
H-Bond Donors8
H-Bond Acceptors19
Rotatable Bonds20
Heavy Atoms114
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001549.61
LogP ≤ 514.52
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1019

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aldehyde', 'substructure': 'N/A'}

Analyze 6-[[(2S)-1-amino-1-oxopropan-2-yl]amino]-2-[1-(2-methylpropyl)indol-5-yl]pyrimidine-4-carboxamide;6-(3-formyl-1H-indol-5-yl)-N-[4-(trifluoromethyl)phenyl]pyridine-2-carboxamide;6-[1-(2-methylpropyl)indol-5-yl]pyridine-2-carbaldehyde;6-[[(3S)-2-oxopyrrolidin-3-yl]amino]-2-[1-[4-(trifluoromethyl)phenyl]benzimidazol-5-yl]pyrimidine-4-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 6-[[(2S)-1-amino-1-oxopropan-2-yl]amino]-2-[1-(2-methylpropyl)indol-5-yl]pyrimidine-4-carboxamide;6-(3-formyl-1H-indol-5-yl)-N-[4-(trifluoromethyl)phenyl]pyridine-2-carboxamide;6-[1-(2-methylpropyl)indol-5-yl]pyridine-2-carbaldehyde;6-[[(3S)-2-oxopyrrolidin-3-yl]amino]-2-[1-[4-(trifluoromethyl)phenyl]benzimidazol-5-yl]pyrimidine-4-carboxamide?
The IUPAC name of 6-[[(2S)-1-amino-1-oxopropan-2-yl]amino]-2-[1-(2-methylpropyl)indol-5-yl]pyrimidine-4-carboxamide;6-(3-formyl-1H-indol-5-yl)-N-[4-(trifluoromethyl)phenyl]pyridine-2-carboxamide;6-[1-(2-methylpropyl)indol-5-yl]pyridine-2-carbaldehyde;6-[[(3S)-2-oxopyrrolidin-3-yl]amino]-2-[1-[4-(trifluoromethyl)phenyl]benzimidazol-5-yl]pyrimidine-4-carboxamide (CID 158029926) is 6-[[(2S)-1-amino-1-oxopropan-2-yl]amino]-2-[1-(2-methylpropyl)indol-5-yl]pyrimidine-4-carboxamide;6-(3-formyl-1H-indol-5-yl)-N-[4-(trifluoromethyl)phenyl]pyridine-2-carboxamide;6-[1-(2-methylpropyl)indol-5-yl]pyridine-2-carbaldehyde;6-[[(3S)-2-oxopyrrolidin-3-yl]amino]-2-[1-[4-(trifluoromethyl)phenyl]benzimidazol-5-yl]pyrimidine-4-carboxamide.
What is the SMILES notation for 6-[[(2S)-1-amino-1-oxopropan-2-yl]amino]-2-[1-(2-methylpropyl)indol-5-yl]pyrimidine-4-carboxamide;6-(3-formyl-1H-indol-5-yl)-N-[4-(trifluoromethyl)phenyl]pyridine-2-carboxamide;6-[1-(2-methylpropyl)indol-5-yl]pyridine-2-carbaldehyde;6-[[(3S)-2-oxopyrrolidin-3-yl]amino]-2-[1-[4-(trifluoromethyl)phenyl]benzimidazol-5-yl]pyrimidine-4-carboxamide?
The canonical SMILES for 6-[[(2S)-1-amino-1-oxopropan-2-yl]amino]-2-[1-(2-methylpropyl)indol-5-yl]pyrimidine-4-carboxamide;6-(3-formyl-1H-indol-5-yl)-N-[4-(trifluoromethyl)phenyl]pyridine-2-carboxamide;6-[1-(2-methylpropyl)indol-5-yl]pyridine-2-carbaldehyde;6-[[(3S)-2-oxopyrrolidin-3-yl]amino]-2-[1-[4-(trifluoromethyl)phenyl]benzimidazol-5-yl]pyrimidine-4-carboxamide is CC(C)Cn1ccc2cc(-c3cccc(C=O)n3)ccc21.CC(C)Cn1ccc2cc(-c3nc(N[C@@H](C)C(N)=O)cc(C(N)=O)n3)ccc21.NC(=O)c1cc(N[C@H]2CCNC2=O)nc(-c2ccc3c(c2)ncn3-c2ccc(C(F)(F)F)cc2)n1.O=Cc1c[nH]c2ccc(-c3cccc(C(=O)Nc4ccc(C(F)(F)F)cc4)n3)cc12.
What is the InChIKey of 6-[[(2S)-1-amino-1-oxopropan-2-yl]amino]-2-[1-(2-methylpropyl)indol-5-yl]pyrimidine-4-carboxamide;6-(3-formyl-1H-indol-5-yl)-N-[4-(trifluoromethyl)phenyl]pyridine-2-carboxamide;6-[1-(2-methylpropyl)indol-5-yl]pyridine-2-carbaldehyde;6-[[(3S)-2-oxopyrrolidin-3-yl]amino]-2-[1-[4-(trifluoromethyl)phenyl]benzimidazol-5-yl]pyrimidine-4-carboxamide?
The InChIKey is FHBDDMQCDRMQOW-XVUAEVNCSA-N. The full InChI is InChI=1S/C23H18F3N7O2.C22H14F3N3O2.C20H24N6O2.C18H18N2O/c24-23(25,26)13-2-4-14(5-3-13)33-11-29-16-9-12(1-6-18(16)33)21-31-17(20(27)34)10-19(32-21)30-15-7-8-28-22(15)35;23-22(24,25)15-5-7-16(8-6-15)27-21(30)20-3-1-2-18(28-20)13-4-9-19-17(10-13)14(12-29)11-26-19;1-11(2)10-26-7-6-13-8-14(4-5-16(13)26)20-24-15(19(22)28)9-17(25-20)23-12(3)18(21)27;1-13(2)11-20-9-8-15-10-14(6-7-18(15)20)17-5-3-4-16(12-21)19-17/h1-6,9-11,15H,7-8H2,(H2,27,34)(H,28,35)(H,30,31,32);1-12,26H,(H,27,30);4-9,11-12H,10H2,1-3H3,(H2,21,27)(H2,22,28)(H,23,24,25);3-10,12-13H,11H2,1-2H3/t15-;;12-;/m0.0./s1.
What are the key properties of 6-[[(2S)-1-amino-1-oxopropan-2-yl]amino]-2-[1-(2-methylpropyl)indol-5-yl]pyrimidine-4-carboxamide;6-(3-formyl-1H-indol-5-yl)-N-[4-(trifluoromethyl)phenyl]pyridine-2-carboxamide;6-[1-(2-methylpropyl)indol-5-yl]pyridine-2-carbaldehyde;6-[[(3S)-2-oxopyrrolidin-3-yl]amino]-2-[1-[4-(trifluoromethyl)phenyl]benzimidazol-5-yl]pyrimidine-4-carboxamide?
6-[[(2S)-1-amino-1-oxopropan-2-yl]amino]-2-[1-(2-methylpropyl)indol-5-yl]pyrimidine-4-carboxamide;6-(3-formyl-1H-indol-5-yl)-N-[4-(trifluoromethyl)phenyl]pyridine-2-carboxamide;6-[1-(2-methylpropyl)indol-5-yl]pyridine-2-carbaldehyde;6-[[(3S)-2-oxopyrrolidin-3-yl]amino]-2-[1-[4-(trifluoromethyl)phenyl]benzimidazol-5-yl]pyrimidine-4-carboxamide has a molecular weight of 1549.61 g/mol, XLogP of 14.52, 20 rotatable bonds, 8 hydrogen bond donors, and 19 hydrogen bond acceptors.
Where does this data come from?
All data for 6-[[(2S)-1-amino-1-oxopropan-2-yl]amino]-2-[1-(2-methylpropyl)indol-5-yl]pyrimidine-4-carboxamide;6-(3-formyl-1H-indol-5-yl)-N-[4-(trifluoromethyl)phenyl]pyridine-2-carboxamide;6-[1-(2-methylpropyl)indol-5-yl]pyridine-2-carbaldehyde;6-[[(3S)-2-oxopyrrolidin-3-yl]amino]-2-[1-[4-(trifluoromethyl)phenyl]benzimidazol-5-yl]pyrimidine-4-carboxamide is sourced from PubChem (CID 158029926), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).